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Substantial effort has been put into the explorationof the biological background of eating disorders,
through family, twin and molecular genetic studies.
Family studies have shown that anorexia (AN) and
bulimia nervosa (BN) are strongly familial, and that
familial etiologic factors appear to be shared by both
disorders. Twin studies often focus on broader phe-
notypes or subthreshold eating disorders. These
studies consistently yielded moderate to substantial
heritabilities. In addition, there has been a prolifera-
tion of molecular genetic studies that focused on
Diagnostic and Statistical Manual of Mental
Disorders (4th ed.; DSM-IV; American Psychiatric
Association, 1994) AN and BN. Seven linkage
regions have been identified in genome-wide
screens. Many genetic association studies have
been performed, but no consistent association
between a candidate gene and AN or BN has been
reported. Larger genetic association studies and col-
laborations are needed to examine the involvement
of several candidate genes and biological pathways
in eating disorders. In addition, twin studies should
be designed to assist the molecular work by further
exploring genetic determinants of endophenotypes,
evaluating the magnitude of contribution to liability
of measured genotypes as well as environmental
risk factors related to eating disorders. In this
manner twin and molecular studies can move the
field forward in a mutually informative way.
Eating disorders are distinguished into anorexia
nervosa (AN), bulimia nervosa (BN) and eating disor-
ders not otherwise specified (EDNOS). The diagnostic
features of AN include severe underweight and an
intense fear of gaining weight or becoming fat. BN is
characterized by recurrent episodes of binge-eating
and compensatory behaviors. Binge-eating disorder,
the most studied form of EDNOS, is characterized by
the occurrence of binge-eating in the absence of com-
pensatory behaviors.
AN and BN mainly affect young women (90% to
95%) and generally start during puberty or early
adulthood. The prevalence among women between 15
and 24 years of age is estimated to be 0.3% for AN
and 1% for BN in industrialized countries (Hoek,
1993; Van Hoeken et al., 1998). Chronicity and mor-
tality of patients with eating disorders are among the
highest of all psychiatric illnesses (Harris &
Barraclough, 1998; Nielsen et al., 1998; Sullivan,
1995). Long-term follow-up studies show a mortality
rate of 5% per decade. Mortality from AN is five
times higher than in a comparable age group (Harris
& Barraclough, 1998). Recent studies show that even
after 10 years, 20% of the individuals continue to
fulfil diagnostic criteria for an eating disorder, while
another 30% show partial symptoms (Steinhausen,
1999; Steinhausen, 2002).
Despite substantial efforts to identify causal path-
ways for AN and BN, very little is known about the
etiology of eating disorders. In longitudinal and cross-
sectional studies, several risk factors have been
identified, including gender, elevated weight and
shape concerns, negative body image, negative self-
evaluation and dieting (Jacobi et al., 2004). For AN,
high-level exercise and perfectionism have been iden-
tified as additional risk factors.
To explore the role of biology in the etiology of
eating disorders, numerous studies have been per-
formed (for a review, see Bulik & Tozzi, 2004; Tozzi
& Bulik, 2003). Family studies have been conducted
to examine whether relatives of patients with AN or
BN have an increased risk of developing an eating dis-
order. Family studies cannot distinguish between the
genetic and environmental contribution to familial
aggregation. By contrast, in twin studies, the similari-
ties and differences between monozygotic (MZ) and
dizygotic (DZ) twins allow us to delineate the nature
and magnitude of genetic and environmental influ-
ences for a particular trait. In the first section, we will
review family and twin studies of AN and BN.
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Evidence of heritability justifies efforts to identify
genetic loci that influence the risk for a trait or disor-
der. The last two decades have witnessed a
proliferation of linkage and association studies of
eating disorders. In the majority of studies candidate
genes were examined based on their hypothesized
function in the etiology of eating disorders. The
second part of this article focuses on the genetic
studies of eating disorders.
Family and Twin Studies
All but one of the family studies of AN and BN
(Logue et al., 1989) reported increased rates of eating
disorders in relatives of patients (Biederman et al.,
1985; Gershon et al., 1983; Grigoroiu-Serbanescu et
al., 2003; Halmi et al., 1991; Herpertz-Dahlmann,
1988; Hudson et al., 1987; Kassett et al., 1989;
Lilenfeld et al., 1998; Stern et al., 1992; Strober et al.,
2000; Strober et al., 2001; Strober et al., 1990;
Strober et al., 1985). Strober et al. (2000) performed
the most extensive family study in eating disorders,
using phenotypes based on the Diagnostic and
Statistical Manual of Mental Disorders (4th ed.; DSM-
IV; American Psychiatric Association, 1994) criteria.
They compared the rate of eating and other psychi-
atric disorders in the relatives of 152 restrictive AN
patients, 171 BN patients and 181 healthy controls.
The risk of developing AN was 11.4 times increased in
relatives of AN patients compared to relatives of
healthy controls, whereas the risk for BN in relatives
of AN patients was 3.5 times increased. Relatives of
BN patients had a 3.7 times increased risk for devel-
oping BN, and a 12.1 times increased risk for
developing AN. Not only do these results suggest that
AN and BN are familial, but also that familial etiolog-
ical factors appear to be shared by AN and BN.
The first heritability studies in twins of AN and
BN were clinical case reports and systematic studies of
clinically ascertained twins (see the first section in
Table 1; Askevold & Heiberg, 1979; Fichter &
Noegel, 1990; Holland et al., 1984; Holland et al.,
1988; Hsu et al., 1990; Nowlin, 1983; Treasure &
Holland, 1990). The criteria applied to define AN and
BN varied considerably between these studies, and
none were based on DSM-IV. Nevertheless, for AN
and BN, the concordance of MZ twins was greater
than for DZ twins, which was more pronounced in
AN. Bulik et al. (2000) reanalyzed the clinical twin
studies of BN and fitted a full ACE model (including
genetic, common environmental and unique environ-
mental factors) to the data from these reports. In this
analysis, concordance rates of 46% in MZ and 26%
in DZ twins resulted in a heritability estimate of 47%
(95% confidence interval [CI] 0–66). It is important to
note that clinical cases are likely to be more severely
affected, and may differ from community cases in
other ways that might bias the results of genetic inves-
tigations (Kendler, 1993). The results obtained in
clinical studies may therefore not be extrapolated to
the total population of affected individuals. But they
may be suitable in detecting a pathway that leads to
the onset of AN or BN.
Three different population-based twin registries
assessed AN and/or BN, namely the Danish Twin
Registry (DTR; Kortegaard et al., 2001), the
Minnesota Twin Family Study (MTFS; Klump et al.,
2001) and the Virginia Twin Registry (VTR; Bulik et
al., 1998; Kendler et al., 1991; Kendler et al., 1995;
Wade, Bulik, Neale, et al., 2000; Walters & Kendler,
1995; Walters et al., 1992). Due to the low prevalence
of both AN and BN, all studies used broader pheno-
types to boost statistical power. The criteria used to
define these broader phenotypes varied considerably
between registries. Partial DSM-IV and Diagnostic
and Statistical Manual of Mental Disorders (3rd ed.,
rev.; DSM-III-R; American Psychiatric Association,
1987) criteria were used in the MTFS and the VTR
respectively, whereas the definitions used in the DTR
were not based on DSM criteria at all. The reported
prevalence for broad AN phenotypes ranged from
2.7% to 4.9% (Klump et al., 2001; Kortegaard et al.,
2001; Wade, Bulik, Neale, et al., 2000; Walters &
Kendler, 1995), all exceeding the estimated population
prevalence of 0.3% by far. For the broad BN pheno-
type the prevalences were around 4% (Bulik et al.,
1998; Kendler et al., 1991; Kendler et al., 1995;
Kortegaard et al., 2001), again considerably higher
than the 1% population prevalence.
In the second section of Table 1, the best fitting
and full twin models of broad AN (if presented in the
original study) are shown. In the best fitting models,
the heritability estimates in the DTR ranged from
48% to 52% (Kortegaard et al., 2001), and in the
MTFS it was estimated at 76% (Klump et al., 2001).
Moreover, Wade, Bulik, Neale, et al. (2000) reported a
heritability estimate of 58%, using a bivariate analysis
in the VTR. In all studies, the remaining variance was
accounted for by unique environmental factors
(Klump et al., 2001; Kortegaard et al., 2001; Wade,
Bulik, Neale, et al., 2000).
The best fitting and full twin models of broad BN
are listed in the final part of Table 1. Both univariate
and bivariate twin analyses of broad BN (Bulik et al.,
1998; Kortegaard et al., 2001; Kendler et al., 1991;
Walters et al., 1992) consistently yielded high heri-
tability estimates, ranging from 50% (Walters et al.,
1992) to 70% (Bulik et al., 1998). In these studies,
individual-specific environmental components
accounted for the remaining variance. In a multivari-
ate analysis, examining BN in combination with five
other psychiatric disorders (Kendler et al., 1995), a
heritability estimate of 30% for broadly defined BN
was obtained. Shared genetic factors were identified
among BN, phobia and generalized anxiety disorder.
Statistical power can be enhanced by incorporating
two occasions of measurement into a twin study. Bulik
et al. (1998) applied this method using data from the
first and third wave of data collection in the VTR to
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Table 1
Twin Studies in Eating Disorders
Subject Sample size Concordance Model Reference Note
MZ DZ MZ DZ a2 c2 e2
Clinical studies
AN
16 — .55 — (Askevold & 
Heiberg, 1979) 
24 2 .59 0 (Nowlin, 1983) Review, criteria unclear
16 14 .72 .13 (Holland et al., 1984) Female–female pairs, Crisp & Russel (1970)
25 20 .71 .10 98 (SE ± 12) (Holland et al., 1988) Female–female pairs, ICD 9 
34 26 .68 .08 100 — — (Treasure & Female–female pairs, EDE
Holland, 1990)
BN
14 17 .35 .29 10 60 30 (Treasure & Female–female pairs, EDE
Holland, 1990)
6 2 .50 0 (Hsu et al., 1990) Female–female pairs, DSM-III-R
6 15 .91 .42 (Fichter & Female–female pairs, DSM-III-R
Noegel, 1990) 
Twin registries
AN (broad)
590 440 .10 .22 (Walters VTR, wave 1, clinical broad AN 
& Kendler, 1995) 
196 105 .40 0 74 (0–94) 0 (0–65) 27 (6–67) (Klump et al., 2001) MTFS, DSM-IV, full model 
196 105 .40 0 76 (35–95) — 24 (5–65) (Klump et al., 2001) MTFS, DSM-IV, best fitting model
190a 248a .18 .07 48 (27–65) — 52 (Kortegaard DTR, definition based 
(.10–.27) (.02–.13) et al., 2001) on 1 item, best fitting model
190a 248a .25 .13 52 (38–65) — 36 (Kortegaard DTR, definition based 
(.18–.33) (.08–.17) et al., 2001) on 2 items, best fitting model
597 433 28 (0–82) 27 (0–67) 45 (17–70) (Wade, Bulik, VTR, DSM-III-R, bivariate analysis major
Neale, et al., 2000) depression, ra = .81, full model 
597 433 58 (33–84) — 42 (16–68) (Wade, Bulik, VTR, DSM-III-R, bivariate analysis major 
Neale, et al., 2000) depression, ra = .58, best fitting 
BN (broad)
590 440 .23 .09 55 0 45 (Kendler et al., 1991) VTR, wave 1, DSM-III-Rb, full model 
590 440 .23 .09 55 — 45 (Kendler et al., 1991) VTR, wave 1, DSM-III-Rb, best fitting model
590 440 .26 .16 38 13 50 (Kendler et al., 1991) VTR, wave 1, DSM-III-Rc, full model
590 440 .26 .16 52 — 48 (Kendler et al., 1991) VTR, wave 1, DSM-III-Rc, best fitting model
497 354 60 — 40 (Bulik et al., 1998) VTR, wave 1, DSM-III-Rd, best fitting model
497 354 68 — 32 (Bulik et al., 1998) VTR, wave 3, DSM-III-Rd, best fitting model
190a 248a .26 .11 61 (44–75) — 24 (Kortegaard 
(.16–.35) (.04–.17) et al., 2001)
590 440 35 22 43 (Walters et al., 1992) VTR, wave 1, DSM-III-Rc, bivariate analysis 
major depression, ra = .26, full model
590 440 50 — 50 (Walters et al., 1992) VTR, wave 1, DSM-III-Rc, bivariate analysis
major depression, ra = .46, best fitting model
590 440 30 41 29 (Kendler et al., 1995) VTR, wave 1, DSM-III-Rc, multivariate 
analysis, best fitting model
497 354 83 (64–100) — 17 (0–36) (Bulik et al., 1998) VTR, wave 1 and 3, DSM-III-Rd, 
incorporation of 2 occasions of 
measurement, best fitting model
Note: Best fitting and full twin models are shown including 95% confidence intervals when reported in the original studies.
a = affected twin pairs: at least one twin endorsed one or more of the eating disorder questions.
b = definition broad BN: definite and probable cases BN based on DSM-III-R.
c = definition broad BN: definite, probable and possible cases BN based on DSM-III-R.
d = definition broad BN: all DSM-III-R criteria minus criterion D (minimum frequency of binge eating).
assess BN. The reliability between these two occasions
of measurement was low (κ = .28), suggesting that
single assessments of the lifetime history of broad BN
are prone to error. When the error of measurement was
incorporated into the structural equation twin model, a
heritability of 83% was estimated for broad BN.
Due to the low prevalence of AN and BN, and sub-
sequently the small numbers of affected twins in the
VTR and MTFS samples, the statistical power, even
when using broader phenotypes, was far from adequate
in these studies as reflected in the broad confidence
intervals around the heritability estimates (Neale et al.,
1994). Although, the sample sizes in the DTR were
much larger, the statistical power in this study was still
insufficient and the diagnostic criteria suboptimal.
In summary, family studies have consistently shown
that AN and BN are strongly familial. The twin studies
in AN and BN are indicative of a modest to consider-
able role of genetic factors in the etiology of broadly
defined eating disorders, component behaviours and
related traits. Due to the relatively low prevalence of
AN and BN, whether a threshold DSM-IV diagnosis
represents a more heritable phenotype than the broad
definition phenotypes used remains unknown.
Molecular Genetic Studies
Linkage Studies
In linkage analysis, the segregation of alleles in families
together with the affected phenotypes is investigated to
localize disease genes or, in general, genes that influence
a quantitative trait (Slagboom & Meulenbelt, 2002).
Relevant for the studies into AN and BN are the
genome-wide marker data that are used to establish the
extent of allele sharing in AN- and BN-affected sibling
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Figure 1
Linkage results of the genome-wide scans in eating disorders, with LOD scores of 1.97 and greater.
Note: I = anorexia nervosa restrictive subtype (chromosome 1 NPL = 3.03, chromosome 4 NPL = 2.44).
II = anorexia nervosa, drive for thinness and obsessionality combined (LOD = 3.46).
III = anorexia nervosa and obsessionality (LOD = 2.22).
IV = bulimia nervosa (chromosome 10 MLS = 2.92, chromosome 14 MLS = 1.97).
V = anorexia nervosa and drive for thinness (LOD = 2.50).
pairs by applying either a model-free or model-based
linkage analysis method. To identify areas of the human
genome that may harbor susceptibility loci for AN and
BN, genome-wide screens have been conducted using
polymorphic markers spanning all chromosomes, in a
collaboration of the Price Foundation (Bulik et al.,
2003; Devlin et al., 2002; Grice et al., 2002; Kaye et
al., 2004; Kaye, Lilenfeld, et al., 2000). 
For AN, probands were included in the study if
they had a lifetime diagnosis of AN, based on DSM-IV
criteria minus criterion D (amenorrhea) with a dura-
tion of at least 3 years, whereas relatives of AN
probands needed to fulfil DSM-IV criteria for an
eating disorder (either AN, BN or EDNOS). Using
these criteria, a total of 229 affected relative pairs
were recruited. To provide better identity by descent
(IBD) estimation, DNA was collected from biological
parents where possible (Kaye, Lilenfeld, et al., 2000).
The BN probands were required to have a lifetime
diagnosis of BN, according to DSM-IV criteria, purging
had to include regular vomiting, and bingeing and vom-
iting must have occurred at least twice a week for a
duration of 6 months. To be included in the study, rela-
tives were required to have a DSM-IV diagnosis of an
eating disorder (either AN, BN or EDNOS). A total of
365 affected relative pairs were recruited. Again DNA
was collected from biological parents where possible
(Kaye et al., 2004).
Figure 1 shows the linkage regions that were
obtained in genome-wide screens (linkage scores of
1.97 or greater) performed in these studies of AN and
BN. In the total sample of AN-affected relative pairs,
none of the linkage peaks had a nonparametric
linkage (NPL) score above 1.80. Linkage analysis per-
formed in the restrictive subtype of AN (n = 37
families), however, yielded a linkage peak at 1p33–36
(NPL score = 3.03), providing suggestive evidence and
a peak at 4q12–14 (NPL score = 2.44; Bergen et al.,
2003; Grice et al., 2002). Within the AN sample, a
quantative trait locus (QTL) analysis was subse-
quently performed with drive for thinness and
obsessionality (Devlin et al., 2002) that showed three
suggestive linkages on chromosome 1q31 (logarithm
of the odds [LOD] score = 3.46 for drive for thinness
and obsessionality combined), 2p11 (LOD score =
2.22 for obsessionality), and 13q13 (LOD score =
2.50 for drive for thinness), respectively.
For the entire BN sample, three regions of linkage
were reported, significant linkage was achieved on chro-
mosome 10p13 (nonparametric multipoint maximum
LOD score [MLS] = 2.92), and suggestive evidence for
linkage was reported for 10p14 (MLS = 2.70) and
14q22–23 (MLS = 1.97). In addition, linkage analysis
was performed in a subset of 133 families, in which at
least two affected individuals reported regular vomiting
behavior. This phenotype was chosen because vomiting
is associated with a more reliable reporting of BN
(Wade, Bulik, & Kendler, 2000), and because of its sub-
stantial heritability (Sullivan et al., 1998a). The analysis
in this subset did not yield any different regions of
linkage, but did increase the linkage peak on chromo-
some 10p13 (LOD score = 3.39).
Genetic Association Studies
In a genetic association study, candidate genes that are
suggested to be involved in the pathophysiology of the
disease can be investigated for their role in the onset
of the trait. In such studies, the allele or genotype
frequencies at markers, single nucleotide polymor-
phisms (SNP), are determined in affected individuals
and compared to those of controls (either population-
or family-based). Association studies are known as an
effective approach to detect the effect of variants
within candidate genes with relatively small effects
(Slagboom & Meulenbelt, 2002).
A variety of genes have been tested in association
studies on eating disorders. Most genes can be classified
in three main biological pathways, namely the sero-
tonin pathway, the catecholamine pathway, and the
pathway involved in neuropeptide and feeding regula-
tion. The serotonin pathway has been most intensively
studied in eating disorders. It is involved in a broad
range of biological, physiological and behavioral func-
tions (Blundell, 1992; Blundell et al., 1995; Halford &
Blundell, 2000; Lucki, 1998; Simansky, 1996).
Serotonin is involved in body weight regulation and
more specifically in eating behavior. In both rodents
and humans, drugs that either directly or indirectly
increased postsynaptic serotonergic stimulation rou-
tinely decreased the consumption of food (Lucki, 1998;
Simansky, 1996). The serotonin pathway has also been
implicated in the development of eating disorders
(Brewerton & Jimerson, 1996; Kaye, 1997;
Monteleone et al., 2000; Weltzin et al., 1994). In long-
term weight-recovered patients with AN or BN, levels
of 5-hydroxyindolacetic acid (5-HIAA), a metabolite of
serotonin, were elevated in cerebrospinal fluid com-
pared to those of controls (Kaye et al., 1998; Kaye et
al., 1991). These results suggest that hyperserotonergic
activity is a trait marker in eating disorders. It is
hypothesized that increased brain serotonin activity
could predispose to the development of eating disor-
ders. In addition, serotonin might also contribute to the
psychopathological features of eating disorders such as
perfectionism, rigidity and obsessionality (Hinney et al.,
2000; Kaye, 1997; Kaye, Klump, et al., 2000).
Within the serotonin system, the serotonin 2A
receptor gene (HTR2A) has received most attention in
association studies. HTR2A is regulated by estrogen
(Fink & Sumner, 1996), which could render a possible
explanation why 90% to 95% of those affected by
AN are female and why the onset of the disorder is
peripubertal. In addition, it has been reported that
recovered anorectics and bulimics have a reduced
HTR2A receptor binding compared to healthy con-
trols (Frank et al., 2002; Kaye et al., 2001). These
findings suggest that alterations in the HTR2A gene
might be involved in the etiology of eating disorders.
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The eating disorder field is characterized by the
performance of many genetic association studies in
small samples that often present contradicting results
(for references, see Appendix: References II). In the
majority of the studies, AN and BN were diagnosed
according to DSM-IV criteria. The general problem of
these studies is their lack of statistical power. When
recalculating the power of these studies, assuming a
dominant model with an allele frequency of .10 and a
relative risk of 2, 93% of the studies (53 out of the 57)
do not have adequate statistical power to detect an
effect. To obtain a power of 80% under these assump-
tions, at least 178 cases and 178 controls are required.
An example of the inconsistency in smaller studies
is the G-1438A polymorphism in the promoter region
of the HTR2A gene. In Caucasians, six case-control
association studies reported a positive association of
the G-1438A polymorphism and AN (Collier et al.,
1997; Enoch et al., 1998; Nacmias et al., 1999; Ricca
et al., 2004; Ricca et al., 2002; Sorbi et al., 1998). In
these studies, a higher frequency of the –1438A allele
and/or –1438 A/A genotype in anorectics compared to
controls was reported. However, six other studies, also
performed in Caucasian populations, did not confirm
this finding (Campbell et al., 1998; Hinney et al.,
1997; Karwautz et al., 2001; Kipman et al., 2002;
Rybakowski et al., 2004; Ziegler et al., 1999). Finally,
two Japanese studies also did not detect association
between the G-1438A polymorphism and AN (Ando
et al., 2001; Nishiguchi et al., 2001).
Meta-analyses provide a quantitative approach for
combining results from different studies on the same
topic. Systematic meta-analyses can be a useful tool in
estimating population-wide effects of genetic risk
factors in human disease (Ioannidis et al., 2001). So in
response to the apparent discrepancies mentioned
above, three meta-analyses have been performed
(Collier et al., 1999; Gorwood et al., 2003; Ziegler et
al., 1999). Collier et al. (1999) conducted a meta-
analysis on four association studies (Campbell et al.,
1998; Collier et al., 1997; Enoch et al., 1998; Sorbi et
al., 1998). In this analysis, a significant association
between the –1438A/A genotype and AN, with an
odds ratio of 2.29, was reported. Ziegler et al. (1999)
performed a meta-analysis based on six studies
(Campbell et al., 1998; Collier et al., 1997; Enoch et
al., 1998; Hinney et al., 1997; Sorbi et al., 1998;
Ziegler et al., 1999), including the four studies used in
the first meta-analysis (Collier et al., 1999), and the
study by Hinney et al. (1997), which did not have a
normal weight control group. This meta-analysis did
not reveal a significant association between the
HTR2A promoter polymorphism and AN. The third
meta-analysis (Gorwood et al., 2003) was based on
nine studies (Campbell et al., 1998; Collier et al.,
1997; Enoch et al., 1998; Hinney et al., 1997; Kipman
et al., 2002; Nacmias et al., 1999; Nishiguchi et al.,
2001; Sorbi et al., 1998; Ziegler et al., 1999), includ-
ing the studies used in the meta-analysis by Ziegler et
al. (1999). One of the additional studies was a
Japanese study (Nishiguchi et al., 2001). In this analy-
sis, the frequency of the –1438A allele in patients with
AN was significantly higher compared to controls.
An important issue concerning the meta-analyses is
whether it is justified to combine the association
studies. First, there is a difference in the type of
control group used. Hinney et al. (1997) used a group
of obese and a group of underweight subjects as the
control group, while all other studies used a normal
weight control sample. Second, A-allele frequencies
found in the Japanese controls (Nishiguchi et al.,
2001) were higher (.54) than those reported in the
Caucasian control sample (.30–.48). In addition, the
frequencies of the –1438 A allele in the different
Caucasian control samples show substantial differ-
ences, ranging from .30 (Ziegler et al., 1999) to .48
(Kipman et al., 2002). The difference of the –1438 A
allele in AN patients is even greater, ranging from .29
(Ziegler et al., 1999) to .57 (Sorbi et al., 1998). These
fluctuating allele frequencies are almost inherent to
small samples because none of the studies are able to
give an accurate estimate of the allele frequencies in
the population.
The performance of these meta-analyses does there-
fore not appear to solve the problem of interpreting the
excess of these small inconsistent association studies in
AN and BN. There is still a discrepancy between the
results, and the choice of study-inclusion criteria
remains arbitrary. A solution to this problem is the per-
formance of larger genetic association studies with
adequate statistical power to detect an effect. Two large
collaborative studies have tested several candidate genes
for association in both AN and BN (Table 2).
Following up their genome-wide screen in AN
(Grice et al., 2002), the collaborative study mentioned
previously performed an association study focusing on
candidate genes positioned under the linkage peak on
chromosome 1p33–36 (Bergen et al., 2003). For their
association study, three candidate genes were tested,
namely the serotonin receptor 1D (HTR1D), opioid
receptor delta 1 (OPRD1) and hypocretin receptor 1
(HCRTR1). The case-control study (based on 196
cases, 98 controls and DSM-IV criteria) yielded a posi-
tive association between one HTR1D (C1080T) and
three OPRD1 (T8214C, G23340A, and A47821G)
polymorphisms in AN. The subsequent transmission
disequilibrium test (TDT) analysis confirmed an asso-
ciation only for the OPRD1 A47821G SNP. However,
after correction for multiple testing only the associa-
tion with the HTR1D C1080T polymorphism
remained statistically significant.
Another large European collaboration tested the
HTR2A (G-1438A SNP), the catechol-o-methyltrans-
ferase (COMT; Val-158-Met SNP), and the
brain-derived neurotrophic factor (BDNF; C-270T
and Val-66-Met SNPs) genes for association in eating
disorders, defined according to DSM-IV criteria
(Gabrovsek et al., 2004; Gorwood et al., 2002;
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Table 2
Candidate Gene Studies Performed by Collaborations
Gene Polymorphism Phenotype N p valuea Reference Note
Serotonin
Serotonin receptor 1D C1080T Anorexia nervosa 196 .01 (Bergen et al., 2003) OR 2.63, TDT ns
HTR1D, Controls 98 .01 (genotype) United States, United Kingdom and Germany
1p36
A2190G Anorexia nervosa 196 ns (Bergen et al., 2003) OR 1.37, TDT 0.04
Controls 98 United States, United Kingdom and Germany
T-628C Anorexia nervosa 196 ns (Bergen et al., 2003) OR 0.72, TDT 0.01
Controls 98 United States, United Kingdom and Germany
T-1123C Anorexia nervosa 196 ns (Bergen et al., 2003) OR 0.73, TDT 0.02
Controls 98 United States, United Kingdom and Germany
Serotonin receptor 2 A, G-1438A Anorexia nervosa 316 ns (Gorwood TDT and HHRR, France, Germany, 
HTR2A, (rs6311) (trios) et al., 2002) United Kingdom, Italy and Spain 
13q14
Catecholamine
Catechol-o- Val-158-Met Anorexia nervosa 266 ns (Gabrovsek OR 0.98, TDT ns
methyltransferase, (rs4680) Controls 418 et al., 2004) Austria, Germany, Italy, Slovenia,
COMT, Spain and United Kingdom 
22q11
Neuropeptide & feeding regulation 
Hypocretin receptor 1 C114T Anorexia nervosa 196 ns (Bergen et al., 2003) Germany, United Kingdom and United States
Orexin 1 receptor, (rs1056526) Controls 98
HCRTR1, A846G Anorexia nervosa 196 ns (Bergen et al., 2003) Germany, United Kingdom and United States
1p35 Controls 98
A7757G Anorexia nervosa 196 ns (Bergen et al., 2003) Germany, United Kingdom and United States
Controls 98
C8793T Anorexia nervosa 196 ns (Bergen et al., 2003) Germany, United Kingdom and United States
Controls 98
Opioid receptor delta-1 T80G Anorexia nervosa 196 ns (Bergen et al., 2003) OR 0.98, TDT ns
OPRD1, (rs1042114) Controls 98 Germany, United Kingdom and United States
1p35
T8214C Anorexia nervosa 196 .045 (Bergen et al., 2003) OR 1.46, TDT ns
(rs536706) Controls 98 Germany, United Kingdom and United States
G23340A Anorexia nervosa 196 .046 (Bergen et al., 2003) OR 0.68, TDT ns
(rs760589) Controls 98 Germany, United Kingdom and United States
A47821G Anorexia nervosa 196 .01 (Bergen et al., 2003) OR 0.61, TDT 0.06
(rs204081) Controls 98 .03 (genotype) Germany, United Kingdom and United States
A51502T Anorexia nervosa 196 ns (Bergen et al., 2003) OR 0.70, TDT 0.06
(rs204076) Controls 98 Germany, United Kingdom and United States
Other candidate genes
Brain-derived C-270T Anorexia nervosa 98 ns (Ribases et al., 2004) France, Germany, Italy, Spain and  
neurotrophic factor, unclassified 347 United Kingdom
BDNF, Anorexia nervosa 308
11p13–14 restrictive
Anorexia nervosa 389
Binge/purge 510
bulimia nervosa
Controls
Anorexia nervosa 219 ns (Ribases et al., 2005) HRR / TDT
restrictive Austria, France, Germany, Italy, Slovenia,
Spain, and United Kingdom
Anorexia nervosa 140
binge/purge
Val-66-Met Anorexia nervosa 98 .0008 (AN vs. C; (Ribases et al., 2004) OR AN 1.37 (Met-allele)
(rs6265) unclassified 347 genotype) OR ANr 1.43 (Met-allele)
Ribases et al., 2004; Ribases et al., 2005). A signifi-
cantly higher frequency of the Met-66-Met genotype
and the Met-66 allele was reported in both AN and
BN cases compared to controls (Ribases et al., 2004;
Ribases et al., 2005). None of the other polymor-
phisms were associated with eating disorders,
although the TDT analysis did reveal an excess of
transmission of the –270C/Met-66 haplotype in the
BDNF gene in restrictive AN.
There is no overlap between the candidate genes
studied in the two collaborations. Subsequently, the
positive results reported for the candidate genes above
are promising, but unless they are replicated in an
independent sample, there is not enough evidence for
a definite association. In addition, the only overlap
between reported linkage regions and studied candi-
date genes is from the study by Bergen et al. (2003).
Interestingly, the HTR2A gene is located near the
linkage peak on chromosome 13q13.
In summary, the eating disorder field is character-
ized by an excess of small genetic association studies.
In order to overcome the problems discussed above,
association studies should be performed based on
large sample sizes. Because of the low prevalence of
eating disorders, it is not an easy task to collect large
numbers of patients. The establishment of more col-
laborations between centers could help to solve this
problem. Another important issue is the choice of
appropriate candidate genes or biological pathways.
Selection of candidate genes can be based on their bio-
logical function and/or their location within the
genome. The serotonergic system remains one of the
most intriguing biological pathways given the role that
serotonin plays in appetite and mood regulation and
given the recent findings from neuroimaging studies
(Frank et al., 2002; Kaye et al., 2001; Kaye et al.,
1998). However, little is known about the biological
underpinnings of eating disorders, and many other
biological pathways may be involved.
Discussion
In the last decade, the number of studies focusing on
the role of genetics in the etiology of eating disorders
has increased enormously. This increase has been
met by some successes in molecular genetic studies,
although the majority of results remain inconclusive.
Genome-wide screens have demonstrated linkage
peaks for AN and BN on chromosomes 1p33–36,
4q13, 10p13 and 14q22–23. Furthermore, one col-
laborative study has incorporated behavioral
covariates into their linkage analyses and identified
three additional suggestive linkage peaks (chromo-
some 1q31, 2p11 and 13q13). To confirm the
linkage findings, further replication studies are
needed. Lander and Kruglyak (1995) propose that
the significant linkage from one or a combination of
initial studies should be confirmed in a further
sample, preferably by an independent group of
investigators. As of the linkage studies in eating dis-
orders have been performed by the same
international multicenter collaboration, replication
in an independent sample is warranted.
Many genetic association studies have been con-
ducted in eating disorders without any definite
conclusion. Typical of the association studies in this
field are the excess of small, discrepant studies. In
the future, more SNPs should be measured per can-
didate gene to truly test a gene for association. For
example, in the HTR2A gene, the G-1438A poly-
morphism has been tested for association in 15
studies. Only two of these studies tested four other
SNPs within this gene for association (Hinney et al.,
1997; Nacmias et al., 1999), and none of the studies
examined haplotypes. The only conclusion that can
be drawn from these studies is that the G-1438A
polymorphism is not associated with eating disor-
ders; however, the HTR2A gene could still be
involved. In addition to more SNPs per candidate
gene, more candidate genes per pathway should also
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Table 2 Continued
Candidate Gene Studies Performed by Collaborations
Gene Polymorphism Phenotype N p valuea Reference Note
Anorexia nervosa 308 .003 (ANr vs. C; OR ANbp 1.29 (Met-allele)
restrictive genotype)
Anorexia nervosa 389 OR BN 1.59 (Met-allele)
binge/purge 510 .012 (ANbp vs. C; France, Germany, Italy, Spain, United Kingdom
Bulimia nervosa genotype)
Controls < .001 (BN vs.
C; genotype)
Anorexia nervosa 219 .019 (ANr C; (Ribases et al., 2005) HRR and TDT
restrictive HRR) Austria, France, Germany, Italy, Slovenia
Anorexia nervosa 140 Spain, United Kingdom 
binge/purge
a = p values are reported for the allele-wise association of the polymorphism, unless stated otherwise.
be examined. The linkage results in eating disorders
should be used more extensively to identify new
candidate genes and pathways. Because of the rarity
of eating disorders, it is nearly impossible to identify
biological pathways involved in the etiology by uti-
lizing prospective study designs. The majority of the
current candidate genes and biological pathways in
eating disorders are adopted from research in other
psychiatric disorders (e.g., the serotonin system in
depression and anxiety disorders). The comorbidity
between depression, anxiety disorders and eating
disorders appears to have a substantial genetic com-
ponent (Kendler et al., 1995; Rowe et al., 2002;
Wade, Bulik, Neale, et al., 2000; Walters et al.,
1992), but this does not necessarily mean that the
genes involved in these disorders will also play a
role in AN and BN. Another method of identifying
biological pathways possibly involved in the etiol-
ogy of eating disorders is based on studies of
individuals who have recovered from AN and BN.
One of the most striking features of the family, twin
and molecular genetic research in eating disorders is
the difference in phenotypes used in the various study
designs. Practically all linkage and genetic association
studies used DSM-IV criteria to define AN and BN.
The strong familiality of the DSM-IV eating disorders
has been demonstrated in family studies (Strober et al.,
2000; Strober et al., 2001). However, twin studies,
both clinical and population-based, have not been able
to obtain an adequate number of affected twins to
determine the heritability of eating disorders according
to DSM-IV criteria. Twin studies did yield moderate to
substantial heritability estimates for the broader eating
disorder phenotypes. However, even when using
broader, more prevalent phenotypes, the studies were
still characterized by low statistical power.
One critical question is how best to integrate twin
and molecular genetic studies when focusing on a rela-
tively rare phenotype. On one hand there is interest in
determining the contribution of genetic and environ-
mental factors to vulnerability to threshold DSM-IV
disorders. This approach could tell us whether the
threshold diagnoses in some way represent more genet-
ically homogeneous entities than broader or
subthreshold entities. Alternatively, greater genetic
homogeneity may best be determined by focusing more
on component behaviors rather than syndromes. There
is no a priori reason to believe that the DSM diagnos-
tic schema represent more ‘genetic’ syndromes that
underlying core behaviors or traits. Indeed, Reichborn-
Kjennerud et al. (2004) have suggested that the
familial resemblance for different symptoms of BN, as
codified by DSM-IV criteria, may have distinct
sources. Binge-eating and vomiting represent more
genetically mediated symptoms and place undue
importance on weight as an indicator of self-evalua-
tion, representing a more environmentally mediated
symptom. Thus, our clinically determined diagnostic
criteria may actually represent frequently co-occurring
mixtures of genetically and environmentally influenced
symptoms that could potentially obscure searches for
susceptibility loci.
Moreover, several studies have demonstrated the
presence of an underlying continuum of liability for
eating disorders (Fairburn & Harrison, 2003; Hay
& Fairburn, 1998; Kendler et al., 1991; Sullivan et
al., 1998b; Walters & Kendler, 1995), and have indi-
cated that the diagnostic entities and thresholds of
the DSM-IV do not adequately capture the eating-
disordered behavior. Thus, both twin and molecular
genetic studies should pay careful attention to the
definition of phenotypes especially when dealing
with a relatively rare set of disorders for which the
underlying neurobiology is not yet fully understood.
Moving forward, what additional value might
twin studies have in the field of eating disorders in
the age of molecular genetics? Twin studies can be
used to identify heritabilities and genetic determi-
nants (loci) of eating disorder–related phenotypes
(endophenotypes) and risk factors or intermediate
phenotypes for AN and BN. Loci for eating disor-
der–related traits can next provide new candidate
gene loci to be tested for association in strict AN
and BN phenotypes, applying a case-control design
in collaborative studies.
The twin study design also enables exploration
of gene–environment interactions. Most traditional
genetic analyses assume that the effects of genes and
environment are additive and that the impact of
genetic factors is equal across diverse environments
(Kendler, 2001). However two other forms of the
joint effect of genes and environment in the etiology
of psychiatric illness are also possible: genes may
control sensitivity to the environment and genes
may alter the probability of exposure to environ-
ments (Kendler & Eaves, 1986). Because of the
complex nature of the etiology of eating disorders,
gene–environmental interactions are expected. Due
to the low prevalence of eating disorders, gene–envi-
ronment interactions should be explored in
endophenotypes and intermediate phenotypes of
AN and BN.
In conclusion, how can we conduct future
studies that maximize our chances of identifying
genes and environmental factors that play a role in
the development of AN and BN? First, sample size
is of critical importance: large (collaborative)
genetic studies should be conducted. Second, twin
studies to identify heritabilities and genetic determi-
nants of endophenotypes, risk factors and
intermediate phenotypes associated with eating dis-
orders should be applied. A combination of twin
and genetic designs may lead to enhanced under-
standing of the complex manner in which genes and
environment interact to increase risk for or confer
protection against serious psychiatric conditions
such as AN and BN.
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